Molecular Docking and Dynamic Studies of a Potential Therapeutic Target Inhibiting Glyoxalase System: Metabolic Action of the 3, 3 '- [3-(5-Chloro-2-Hydroxyphenyl)-3-Oxopropane-1, 1-Diyl]- Bis-4-Hydroxycoumarin Leads Overexpression of the Intracellular Level of Methylglyoxal and Induction of a Pro-Apoptotic Phenomenon in a Hepatocellular Carcinoma Model